Annual Total Liabilities
$335.78 M
+$28.15 M+9.15%
December 31, 2023
Summary
- As of February 7, 2025, ABCL annual total liabilities is $335.78 million, with the most recent change of +$28.15 million (+9.15%) on December 31, 2023.
- During the last 3 years, ABCL annual total liabilities has risen by +$160.75 million (+91.84%).
- ABCL annual total liabilities is now at all-time high.
Performance
ABCL Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$314.73 M
+$13.22 M+4.38%
September 30, 2024
Summary
- As of February 7, 2025, ABCL quarterly total liabilities is $314.73 million, with the most recent change of +$13.22 million (+4.38%) on September 30, 2024.
- Over the past year, ABCL quarterly total liabilities has increased by +$13.22 million (+4.38%).
- ABCL quarterly total liabilities is now -18.20% below its all-time high of $384.78 million, reached on March 31, 2022.
Performance
ABCL Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ABCL Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.2% | +4.4% |
| 3 y3 years | +91.8% | +43.5% |
| 5 y5 years | +3297.5% | +2277.9% |
ABCL Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +14.7% | -18.2% | +8.8% |
| 5 y | 5-year | at high | +2436.8% | -18.2% | +2277.9% |
| alltime | all time | at high | +3297.5% | -18.2% | +2277.9% |
AbCellera Biologics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $314.73 M(+4.4%) |
| Jun 2024 | - | $301.51 M(-9.5%) |
| Mar 2024 | - | $333.18 M(-0.8%) |
| Dec 2023 | $335.78 M(+9.1%) | $335.78 M(+1.9%) |
| Sep 2023 | - | $329.42 M(-3.8%) |
| Jun 2023 | - | $342.34 M(+18.3%) |
| Mar 2023 | - | $289.42 M(-5.9%) |
| Dec 2022 | $307.63 M | $307.63 M(+1.8%) |
| Sep 2022 | - | $302.24 M(-20.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $380.93 M(-1.0%) |
| Mar 2022 | - | $384.78 M(+31.4%) |
| Dec 2021 | $292.84 M(+67.3%) | $292.84 M(+33.5%) |
| Sep 2021 | - | $219.34 M(+19.1%) |
| Jun 2021 | - | $184.18 M(+7.5%) |
| Mar 2021 | - | $171.40 M(-2.1%) |
| Dec 2020 | $175.03 M(+1222.4%) | $175.03 M(+229.3%) |
| Sep 2020 | - | $53.15 M(+301.5%) |
| Dec 2019 | $13.24 M(+33.9%) | $13.24 M |
| Dec 2018 | $9.88 M | - |
FAQ
- What is AbCellera Biologics annual total liabilities?
- What is the all time high annual total liabilities for AbCellera Biologics?
- What is AbCellera Biologics annual total liabilities year-on-year change?
- What is AbCellera Biologics quarterly total liabilities?
- What is the all time high quarterly total liabilities for AbCellera Biologics?
- What is AbCellera Biologics quarterly total liabilities year-on-year change?
What is AbCellera Biologics annual total liabilities?
The current annual total liabilities of ABCL is $335.78 M
What is the all time high annual total liabilities for AbCellera Biologics?
AbCellera Biologics all-time high annual total liabilities is $335.78 M
What is AbCellera Biologics annual total liabilities year-on-year change?
Over the past year, ABCL annual total liabilities has changed by +$28.15 M (+9.15%)
What is AbCellera Biologics quarterly total liabilities?
The current quarterly total liabilities of ABCL is $314.73 M
What is the all time high quarterly total liabilities for AbCellera Biologics?
AbCellera Biologics all-time high quarterly total liabilities is $384.78 M
What is AbCellera Biologics quarterly total liabilities year-on-year change?
Over the past year, ABCL quarterly total liabilities has changed by +$13.22 M (+4.38%)